OSAHS IN ELDERLY PATIENTS WITH INSOMNIA Pilot study Céline Degrande Justine Degrande Justine Mestdagh Astrid Verschaeve Supervisor Prof. Dr. Degryse
Aug 17, 2015
OSAHS IN ELDERLY PATIENTS WITH INSOMNIAPilot studyCéline DegrandeJustine DegrandeJustine MestdaghAstrid VerschaeveSupervisor Prof. Dr. Degryse
3
Goal of the Pilot Study
• Prevalence of OSAHS in elderly patients with insomnia
• Validity and practical feasibility of questionnaires
4
A little quiz…
• How often do you think older patients complain of sleep disturbances such as insomnia?o 25%o 50%o 75%o 90%o I don’t know
5
Background: Insomnia• Dissatisfaction with either duration or quality
of sleep.
• 3 fundamental criteria• recurrent• despite adequate opportunities for sleep.• impairment of daytime functioning.
• Most common comorbidities:• psychiatric illness • sleep disordered breathing: OSAHS
• Associated with older age – underdiagnosis:• ‘Ageism’• mental illnesses – cognitive disorders• threshold consulting GP• burden of PSG
6
Background: OSAHS• Prevalence:
o 30-60 years:• ♂: 4%• ♀: 2%
o ↑ prevalence with age: • ♂: 28-62% • ♀: 19,5-60%
• Symptoms:o excessive daytime sleepinesso snoring
• Risk factors: o obesity, male gender, ageing, familial
history, sedating medication,…
• Comorbidities: o cardiovascular o metabolic o neurobehavioral
• Diagnosis:o PSG vs portable device (Brizzy®)
7
Background: Questionnaires
• Insomnia:o ISI
• Sleep quality: o PSQIo ESS
• OSAHS:o BQo STOP-BANG
• Snoring, Tired, Observed, blood Pressure, BMI, Age, Neck circumference, Gender
11
Methods
• Exclusion criteriao terminal patients (life expectancy < 3 months)o diagnosis of dementia (MMSE < 24) o acute precipitating factor for insomnia (physical or
psychological) o Already diagnosed with OSAHS by PSG
• Patients already taking sleep medication NOT excluded!
13
Methods
• Home visito Anamnesis
• History patient• CV RF (smoking, alcohol, familial history,
hypertension, hypercholesterolemia)• Medication use
o Clinical examination• Height, weight, neck circumference,
abdominal circumference, blood pressure,
heart rhythm
30
Results:Sensitivity, Specificity, PPV, NPV, AUC and p-value of parameters in Brizzy® reports using optimal cut-off values
34
Discussion
• Strenghts o Uniformo First step in an unexplored domain
• Limitations o Sample sizeo Brizzy as golden standard o Interobserver variability
35
Discussion
• Underdiagnosis
• Case-finding protocol and ISI as screening tool highly suitable
• Patient characteristics
• RDI – ODI – CT SpO2 < 90%
• Brizzy as a valid ambulant alternative
• ESS – BQ valid questionnaires with optimal cut-off
Conclusion
• OSAHS: severe underdiagnosis • Brizzy as a practical and feasible alternative • Questionnaires in screening
36